Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5 to reflect a new build.
    Difference
    0.0%
    Check dated 2026-06-05T09:20:10.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.4 from v3.5.3, signaling a maintenance update to the page content. This change represents an administrative refresh rather than a substantive alteration to the study record.
    Difference
    0.0%
    Check dated 2026-05-14T23:03:49.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    - The page now shows Revision: v3.5.3, replacing the earlier Revision: v3.5.2. This is a minor page/document revision update and does not modify study data or functionality.
    Difference
    0.0%
    Check dated 2026-04-30T16:27:48.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T09:57:06.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision notes updated: added 'Revision: v3.5.0' and removed 'Revision: v3.4.3'.
    Difference
    0.0%
    Check dated 2026-03-25T20:13:27.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3 (replacing the previous v3.4.2).
    Difference
    0.0%
    Check dated 2026-03-11T14:05:12.000Z thumbnail image

Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.